[
  {
    "id": "main1_001_mmvd_b2",
    "topic": "cardiology",
    "stem": "A 9-year-old male neutered Cavalier King Charles Spaniel is presented for an annual exam. The owner reports the dog is still active and eating normally, with only occasional soft nighttime cough and no exercise collapse. On exam you find a grade III/VI left apical systolic murmur, normal perfusion, and no pulmonary crackles. Thoracic radiographs show left atrial and mild left ventricular enlargement without pulmonary venous congestion or edema. Echocardiography confirms myxomatous mitral valve disease with mitral regurgitation and moderate left atrial dilation. What is the most appropriate next management step now?",
    "options": {
      "A": "Start furosemide and oxygen therapy immediately",
      "B": "Start pimobendan to delay progression to CHF",
      "C": "Start enalapril as primary disease-modifying therapy",
      "D": "No cardiac medications and recheck in 12 months"
    },
    "correct": "B",
    "explanation": "This is preclinical MMVD with remodeling (Stage B2). Pimobendan is indicated to delay CHF onset.",
    "decision_framework": "Stage first: B1 (no enlargement), B2 (enlargement without edema), or CHF (edema/distress).",
    "key_triggers": [
      "MMVD confirmed by murmur plus echocardiography",
      "Cardiomegaly/LA enlargement is present",
      "No pulmonary edema or crackles, so this is not active CHF"
    ],
    "eliminate_wrong": {
      "A": "Acute CHF protocol is for pulmonary edema or severe respiratory distress, which are absent here.",
      "C": "ACE inhibitors are not the primary tested move for Stage B2 in this pattern.",
      "D": "No-treatment logic fits B1, not B2 with documented enlargement."
    },
    "speed_training": "No edema plus cardiomegaly in MMVD points to B2, then choose pimobendan.",
    "navle_rule": "Treat Stage B2. Do not medicate Stage B1.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_002_acute_chf",
    "topic": "cardiology",
    "stem": "A 10-year-old small-breed dog with known chronic mitral valve disease presents for acute respiratory distress that began overnight. The patient is anxious, orthopneic, tachypneic, and has diffuse inspiratory crackles on thoracic auscultation. Pulse oximetry is low, and thoracic radiographs confirm cardiomegaly with cardiogenic pulmonary edema. The owner asks whether to wait for complete echocardiography before treatment. In this immediate setting, what is the best priority action?",
    "options": {
      "A": "Wait for complete echocardiography before treatment",
      "B": "Start oxygen and furosemide immediately",
      "C": "Start oral cough suppressant only",
      "D": "Start pimobendan only and discharge"
    },
    "correct": "B",
    "explanation": "This is acute cardiogenic pulmonary edema. Stabilization with oxygen and diuresis is the first move.",
    "decision_framework": "In respiratory distress with edema, stabilize first; detailed staging comes after oxygenation/perfusion support.",
    "key_triggers": [
      "Respiratory distress with crackles",
      "Pulmonary edema confirmed on imaging",
      "This is decompensated CHF, not preclinical disease"
    ],
    "eliminate_wrong": {
      "A": "Deferring therapy risks deterioration; acute edema requires immediate stabilization.",
      "C": "Symptom suppression alone does not treat life-threatening edema.",
      "D": "Pimobendan can be part of long-term care, but immediate edema control is urgent."
    },
    "speed_training": "Dyspnea plus edema equals oxygen and loop diuretic first.",
    "navle_rule": "Acute CHF is a stabilize-first scenario.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_003_dcm_occult",
    "topic": "cardiology",
    "stem": "A 6-year-old Doberman Pinscher is referred after screening echocardiography showed left ventricular systolic dysfunction and chamber dilation consistent with dilated cardiomyopathy. The dog has occasional fatigue but no resting dyspnea, no crackles, and thoracic radiographs show no pulmonary edema. Intermittent ventricular ectopy is noted on rhythm monitoring. You need to choose the most appropriate immediate pathway for an occult, non-congestive stage. Which next step is best?",
    "options": {
      "A": "Start furosemide as first-line therapy",
      "B": "Start pimobendan and arrange rhythm monitoring",
      "C": "No treatment until CHF develops",
      "D": "Immediate synchronized cardioversion"
    },
    "correct": "B",
    "explanation": "Occult DCM with dilation is managed proactively, while diuretics are reserved for edema/CHF.",
    "decision_framework": "Separate occult remodeling from overt CHF before selecting therapy.",
    "key_triggers": [
      "DCM structural disease is present",
      "No pulmonary edema at this time",
      "Risk of progression and arrhythmia still exists"
    ],
    "eliminate_wrong": {
      "A": "Diuretics are primarily for congestion/edema, not occult non-congestive disease.",
      "C": "Waiting can miss the benefit of early stage-appropriate intervention.",
      "D": "Cardioversion is not indicated without unstable tachyarrhythmia context."
    },
    "speed_training": "Dilation without edema is an occult pathway, not an acute CHF pathway.",
    "navle_rule": "Use stage-based treatment: occult DCM differs from congestive DCM.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_004_vt_assume",
    "topic": "cardiology",
    "stem": "A middle-aged dog presents collapsed and weak with pale mucous membranes, prolonged capillary refill time, and poor peripheral pulses. ECG shows a very rapid wide-complex tachycardia around 230 bpm, and Doppler blood pressure is low. The team is debating whether this might be supraventricular tachycardia with aberrancy versus ventricular tachycardia. In an unstable patient where perfusion is compromised, what is the most appropriate immediate treatment approach?",
    "options": {
      "A": "Assume SVT and give diltiazem first",
      "B": "Assume ventricular tachycardia and treat promptly (lidocaine if appropriate)",
      "C": "Delay treatment until Holter results return",
      "D": "Send home with oral beta-blocker only"
    },
    "correct": "B",
    "explanation": "In unstable canine wide-complex tachycardia, immediate VT-directed management is prioritized.",
    "decision_framework": "Treat the dangerous rhythm pattern first, then refine diagnosis once stabilized.",
    "key_triggers": [
      "Wide-complex rapid rhythm",
      "Perfusion compromise",
      "Emergency rhythm control needed"
    ],
    "eliminate_wrong": {
      "A": "Treating as benign SVT first can delay life-saving VT therapy.",
      "C": "Holter is not an immediate stabilization tool.",
      "D": "Outpatient-only plan is unsafe in unstable tachyarrhythmia."
    },
    "speed_training": "Wide-complex plus instability should trigger VT-first emergency logic.",
    "navle_rule": "Stabilize life-threatening arrhythmias before definitive outpatient workup.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_005_aki_ckd",
    "topic": "nephrology",
    "stem": "An older mixed-breed dog has a several-month history of weight loss, intermittent vomiting, reduced appetite, and increased drinking and urination. Laboratory testing shows persistent azotemia and hyperphosphatemia, and CBC reveals non-regenerative anemia. Abdominal ultrasound demonstrates bilaterally small, irregular kidneys with reduced corticomedullary definition. The clinician must decide whether this pattern is most consistent with acute kidney injury or chronic kidney disease. What is the best interpretation?",
    "options": {
      "A": "Acute kidney injury is most likely",
      "B": "Chronic kidney disease is most likely",
      "C": "Post-renal azotemia from acute obstruction is most likely",
      "D": "Primary hepatic failure is most likely"
    },
    "correct": "B",
    "explanation": "Small irregular kidneys with chronic changes and anemia fit CKD more than AKI.",
    "decision_framework": "Use chronicity markers (body condition, anemia, kidney size/architecture) to distinguish CKD from AKI.",
    "key_triggers": [
      "Small irregular kidneys",
      "Non-regenerative anemia",
      "Longer-duration clinical signs"
    ],
    "eliminate_wrong": {
      "A": "AKI typically has abrupt onset and often normal-to-enlarged kidneys early.",
      "C": "Post-renal patterns rely on obstruction evidence not provided here.",
      "D": "The dominant pattern is renal, not hepatic."
    },
    "speed_training": "Small irregular kidneys plus anemia usually means chronic renal disease.",
    "navle_rule": "Kidney size and chronic systemic clues are high-yield AKI/CKD discriminators.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_006_struvite_dog",
    "topic": "urology",
    "stem": "A female Miniature Schnauzer has recurrent dysuria, pollakiuria, and intermittent hematuria despite previous short antibiotic courses. Urinalysis shows alkaline urine with struvite crystals, urine culture is positive for a urease-producing organism, and abdominal imaging identifies radiopaque cystoliths in the bladder. There is no urethral obstruction or emergency indication for immediate surgery. Based on common canine struvite pathophysiology, what is the most appropriate initial management strategy?",
    "options": {
      "A": "Medical dissolution diet with culture-directed antibiotics",
      "B": "Immediate nephrectomy",
      "C": "No treatment unless obstruction develops",
      "D": "Prednisone as primary therapy"
    },
    "correct": "A",
    "explanation": "Canine struvite stones are often infection-associated and commonly managed with dissolution plus antimicrobial control.",
    "decision_framework": "Identify stone type and infection status before deciding dissolve versus remove surgically.",
    "key_triggers": [
      "Struvite identification",
      "Concurrent bacterial UTI",
      "No immediate emergency obstruction in stem"
    ],
    "eliminate_wrong": {
      "B": "Nephrectomy is unrelated to routine bladder struvite management.",
      "C": "Untreated infection stones risk persistent disease and recurrence.",
      "D": "Steroids are not primary therapy for infection-associated urolithiasis."
    },
    "speed_training": "Dog struvite with UTI usually enters dissolve-plus-antibiotic pathway.",
    "navle_rule": "Treat both the stone chemistry and the infection driver.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_007_lepto_treat_now",
    "topic": "infectious-disease",
    "stem": "A young adult working dog presents with fever, vomiting, lethargy, and rapidly worsening azotemia. The patient also has mild icterus, thrombocytopenia, and recent exposure history to standing water and wildlife-contaminated environments. Leptospirosis is high on the differential list, but confirmatory testing is still pending. Because both clinical outcome and zoonotic exposure are concerns, what is the most appropriate immediate clinical approach?",
    "options": {
      "A": "Delay treatment until convalescent titers are back",
      "B": "Start appropriate antimicrobials and zoonotic precautions immediately",
      "C": "Give only antiemetics and observe",
      "D": "Use corticosteroids as sole first-line treatment"
    },
    "correct": "B",
    "explanation": "Leptospirosis is both time-sensitive and zoonotic, so early treatment and biosecurity are key.",
    "decision_framework": "When clinical suspicion is high and public-health risk exists, treat while confirmatory testing proceeds.",
    "key_triggers": [
      "Compatible multi-system illness",
      "Renal/hepatic involvement pattern",
      "Zoonotic transmission concern"
    ],
    "eliminate_wrong": {
      "A": "Waiting for delayed confirmation can worsen outcome and exposure risk.",
      "C": "Supportive care alone misses disease-modifying treatment needs.",
      "D": "Steroids are not first-line monotherapy for suspected lepto."
    },
    "speed_training": "High suspicion leptospirosis means treat now and protect staff/owners.",
    "navle_rule": "Do not delay leptospirosis therapy for perfect confirmation in unstable timelines.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_008_hepatic_encephalopathy",
    "topic": "hepatology",
    "stem": "A small-breed dog with chronic hepatic disease develops episodic disorientation, aimless pacing, and intermittent ptyalism that worsens after high-protein meals. Blood work suggests hepatic dysfunction, fasting ammonia is elevated, and no primary intracranial lesion is currently suspected. The team wants to choose first-line medical therapy targeting the likely mechanism of neurologic signs. What is the most appropriate immediate management priority?",
    "options": {
      "A": "Lactulose-centered ammonia-lowering strategy",
      "B": "High-protein unrestricted diet without adjuncts",
      "C": "Furosemide as first-line neurologic treatment",
      "D": "Immediate chemotherapy"
    },
    "correct": "A",
    "explanation": "Hepatic encephalopathy management targets ammonia reduction and trigger control, with lactulose as a core intervention.",
    "decision_framework": "Recognize neuro signs from metabolic hepatic failure and treat toxin load rapidly.",
    "key_triggers": [
      "Neurologic episodes with liver disease",
      "Hyperammonemia pattern",
      "Need for ammonia-lowering therapy"
    ],
    "eliminate_wrong": {
      "B": "Uncontrolled high protein can worsen encephalopathy in susceptible cases.",
      "C": "Loop diuretics do not address ammonia-driven neurologic dysfunction.",
      "D": "Chemotherapy is unrelated to first-line HE stabilization."
    },
    "speed_training": "Neuro signs plus hepatic failure should trigger HE protocol, not primary neurologic drug pathways.",
    "navle_rule": "Treat hepatic encephalopathy by reducing ammonia and correcting precipitating factors.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_009_pancreatitis_severity",
    "topic": "gastroenterology",
    "stem": "An overweight middle-aged dog presents with acute vomiting, severe cranial abdominal pain, tachycardia, and depression. During triage, perfusion parameters worsen: mucous membranes are tacky, blood pressure is low, and lactate is elevated. Point-of-care findings support severe pancreatitis with systemic inflammatory response and possible shock physiology. Before advanced diagnostics are expanded, what is the most appropriate immediate treatment priority?",
    "options": {
      "A": "Aggressive stabilization with fluids, analgesia, and monitoring",
      "B": "Discharge with oral antacid only",
      "C": "Delay treatment until pancreatic biopsy",
      "D": "Start long-acting steroid as sole therapy"
    },
    "correct": "A",
    "explanation": "Severe pancreatitis with shock/SIRS requires immediate supportive critical care rather than delayed diagnostics.",
    "decision_framework": "Triage severity first; unstable perfusion means resuscitate before advanced diagnostics.",
    "key_triggers": [
      "Hemodynamic instability",
      "SIRS/shock indicators",
      "Need for ICU-level supportive care"
    ],
    "eliminate_wrong": {
      "B": "Outpatient symptomatic care is unsafe in shock physiology.",
      "C": "Resuscitation should not wait for invasive confirmation.",
      "D": "Single-drug steroid strategy is not standard first-line severe pancreatitis care."
    },
    "speed_training": "Pancreatitis with shock signs equals critical care pathway, not routine outpatient protocol.",
    "navle_rule": "Severity stratification determines urgency and care setting.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_010_imtp",
    "topic": "hematology",
    "stem": "A dog is admitted for spontaneous petechiae, ecchymoses, intermittent epistaxis, and blood-tinged stool. Platelet count is profoundly decreased, while coagulation screening does not indicate classic disseminated consumptive coagulopathy as the primary process. The patient is at high hemorrhage risk and needs urgent direction. In this context, what is the most appropriate next therapeutic pathway?",
    "options": {
      "A": "Begin immunosuppressive treatment for IMTP framework",
      "B": "Start aspirin for platelet support",
      "C": "Observe at home and recheck in 2 weeks",
      "D": "No therapy unless hematocrit drops"
    },
    "correct": "A",
    "explanation": "This pattern supports immune-mediated thrombocytopenia requiring prompt immunosuppressive management.",
    "decision_framework": "Active bleeding plus very low platelets requires urgent IMTP-oriented treatment after triage for alternatives.",
    "key_triggers": [
      "Mucosal bleeding signs",
      "Severe thrombocytopenia",
      "No immediate evidence of another dominant cause in stem"
    ],
    "eliminate_wrong": {
      "B": "Antiplatelet drugs can worsen hemorrhage in severe thrombocytopenia.",
      "C": "Delaying treatment in active bleeding is unsafe.",
      "D": "Platelet crisis can be life-threatening even before anemia develops."
    },
    "speed_training": "Bleeding plus very low platelets should trigger IMTP emergency logic.",
    "navle_rule": "Do not use platelet-inhibiting drugs in severe thrombocytopenic bleeding patterns.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_011_megaesophagus",
    "topic": "internal-medicine",
    "stem": "A large-breed dog with chronic regurgitation and progressive weight loss has repeated episodes of coughing after meals. Thoracic imaging supports generalized megaesophagus, and history suggests previous aspiration events. The owner asks for the most important baseline management action to reduce immediate respiratory complications while further etiologic workup continues. Which step is most appropriate now?",
    "options": {
      "A": "Upright feeding strategy with aspiration-risk prevention",
      "B": "High-volume bolus feeding in lateral recumbency",
      "C": "Immediate loop diuretic protocol",
      "D": "No feeding modification needed"
    },
    "correct": "A",
    "explanation": "Gravity-assisted feeding and aspiration prevention are core baseline interventions in megaesophagus care.",
    "decision_framework": "Protect airway first while investigating underlying causes.",
    "key_triggers": [
      "Regurgitation (not vomiting) pattern",
      "Known aspiration-pneumonia risk",
      "Need for practical feeding-position intervention"
    ],
    "eliminate_wrong": {
      "B": "Recumbent large-volume feeding increases regurgitation/aspiration risk.",
      "C": "Diuretics do not address esophageal motility failure.",
      "D": "Feeding posture is central, not optional, in baseline control."
    },
    "speed_training": "Megaesophagus questions often test airway protection and feeding mechanics first.",
    "navle_rule": "Prevent aspiration while evaluating etiology.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_012_mct_preop",
    "topic": "oncology",
    "stem": "A Boxer has a cutaneous mass diagnosed as mast cell tumor by cytology and is scheduled for surgical excision. The team notes prior local swelling and erythema after manipulation of the lesion, consistent with mediator release risk. You want to reduce perioperative complications from histamine-related effects while planning definitive tumor control. Which medication concept is most appropriate in the perioperative plan?",
    "options": {
      "A": "Use histamine-blockade strategy perioperatively",
      "B": "Use morphine to maximize histamine release",
      "C": "No perioperative planning is needed",
      "D": "Use only thyroid hormone support"
    },
    "correct": "A",
    "explanation": "Mast cell tumor handling can trigger histamine-mediated effects, so perioperative blockade planning is appropriate.",
    "decision_framework": "Separate definitive tumor control from perioperative mediator-risk mitigation.",
    "key_triggers": [
      "Confirmed/suspected mast cell tumor",
      "Surgical manipulation planned",
      "Need to reduce mediator-release complications"
    ],
    "eliminate_wrong": {
      "B": "Avoid choices that increase histamine release in this context.",
      "C": "Ignoring perioperative mediator risk is unsafe.",
      "D": "Thyroid support is unrelated to mast-cell mediator management."
    },
    "speed_training": "Mast cell peri-op questions usually test histamine-risk mitigation before incision.",
    "navle_rule": "Plan both tumor control and mediator protection.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_013_pericardial_tamponade",
    "topic": "emergency",
    "stem": "A large-breed dog presents weak and intermittently collapsing with tachycardia, muffled heart sounds, weak pulses, and jugular distension. Focused ultrasound confirms significant pericardial effusion with cardiac tamponade physiology and right-sided filling compromise. The team discusses whether to stabilize medically first or directly relieve the mechanical problem. What is the most appropriate immediate intervention?",
    "options": {
      "A": "Pericardiocentesis",
      "B": "High-dose furosemide only",
      "C": "Delay intervention until full oncology staging",
      "D": "Oral bronchodilator trial"
    },
    "correct": "A",
    "explanation": "Tamponade is a mechanical filling problem; immediate pericardial drainage is the priority.",
    "decision_framework": "If circulation is impaired by pericardial pressure, relieve pressure first.",
    "key_triggers": [
      "Classic tamponade exam findings",
      "Effusion confirmed",
      "Hemodynamic compromise"
    ],
    "eliminate_wrong": {
      "B": "Diuretics do not resolve the compressive pericardial constraint.",
      "C": "Cause workup comes after hemodynamic stabilization.",
      "D": "Bronchodilators do not treat tamponade physiology."
    },
    "speed_training": "Muffled sounds plus poor pulses plus JVD should trigger tamponade drainage logic.",
    "navle_rule": "Stabilize first, then investigate etiology.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_014_tension_pneumothorax",
    "topic": "emergency",
    "stem": "After blunt thoracic trauma, a dog is severely dyspneic with increased respiratory effort, hyperresonant thorax, and rapidly worsening oxygenation. The clinician strongly suspects tension pneumothorax based on examination, but complete radiographs are not yet obtained. Because ventilation is failing, the next step must prioritize life-saving physiology over full imaging confirmation. What should be done immediately?",
    "options": {
      "A": "Immediate thoracocentesis before waiting for radiographs",
      "B": "Wait for complete CT before intervention",
      "C": "Start oral antitussive and observe",
      "D": "Treat only with IV fluids"
    },
    "correct": "A",
    "explanation": "Suspected tension pneumothorax is a decompress-now emergency; imaging can follow stabilization.",
    "decision_framework": "Prioritize life-saving decompression when clinical signs fit pressure pneumothorax.",
    "key_triggers": [
      "Acute severe dyspnea",
      "Trauma context",
      "Clinical suspicion of tension physiology"
    ],
    "eliminate_wrong": {
      "B": "Delaying decompression for imaging can be fatal.",
      "C": "Antitussives do not resolve pleural air under pressure.",
      "D": "Fluids alone do not fix mechanical respiratory compromise."
    },
    "speed_training": "When chest pressure threatens ventilation, tap first and image second.",
    "navle_rule": "Emergency decompression precedes confirmatory imaging in unstable cases.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_015_aspiration_pneumonia",
    "topic": "respiratory",
    "stem": "A dog with chronic regurgitation develops fever, productive cough, tachypnea, and increased respiratory effort over 24 hours. Thoracic auscultation reveals crackles in dependent lung fields, and aspiration pneumonia is strongly suspected. The team needs the best next diagnostic step to confirm pulmonary involvement and severity before tailoring full therapy. Which option is most appropriate?",
    "options": {
      "A": "Thoracic radiographs",
      "B": "Only abdominal ultrasound",
      "C": "No diagnostics, start long-term steroids",
      "D": "Delay all testing for 72 hours"
    },
    "correct": "A",
    "explanation": "Thoracic radiographs are central for confirming aspiration pneumonia pattern and severity.",
    "decision_framework": "Confirm pulmonary involvement and severity, then tailor antimicrobial/supportive plan.",
    "key_triggers": [
      "Aspiration risk history",
      "New respiratory signs",
      "Need to localize pulmonary pathology"
    ],
    "eliminate_wrong": {
      "B": "Abdominal imaging does not establish pulmonary infiltrate severity.",
      "C": "Empiric long-term steroid-first strategy is not standard here.",
      "D": "Delaying evaluation can worsen hypoxemia and infection burden."
    },
    "speed_training": "Aspiration concern with respiratory signs should trigger thoracic imaging quickly.",
    "navle_rule": "Diagnose chest disease directly when airway/lung signs are present.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_016_parvo_first12h",
    "topic": "infectious-disease",
    "stem": "An unvaccinated puppy presents with acute vomiting, hemorrhagic diarrhea, severe lethargy, dehydration, and marked leukopenia. The patient is weak and at risk for septic complications, and parvoviral enteritis is high on the differential. In the first treatment hours, the team must prioritize both contagion control and hemodynamic stabilization. What is the most appropriate initial sequence?",
    "options": {
      "A": "Immediate isolation with aggressive fluid/supportive protocol",
      "B": "Wait for complete viral panel before precautions",
      "C": "Outpatient oral meds only",
      "D": "High-dose NSAID protocol"
    },
    "correct": "A",
    "explanation": "Early parvovirus care is isolation plus hemodynamic/supportive stabilization in the first hours.",
    "decision_framework": "Handle contagion control and perfusion support in parallel from the start.",
    "key_triggers": [
      "High-risk signalment and GI signs",
      "Leukopenia supports severe viral enteritis concern",
      "Need for both infection control and resuscitation"
    ],
    "eliminate_wrong": {
      "B": "Waiting delays critical containment and stabilization.",
      "C": "Severe suspected parvo generally needs inpatient aggressive support.",
      "D": "NSAID-first approach can be harmful and misses core resuscitation needs."
    },
    "speed_training": "Parvo pattern means isolate first and resuscitate early.",
    "navle_rule": "In contagious critical GI disease, biosecurity and stabilization are immediate priorities.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_017_dmvd_b2_cough_trap",
    "topic": "cardiology",
    "stem": "A small-breed senior dog with chronic cough is referred after cardiac workup shows degenerative mitral valve disease with left atrial and ventricular enlargement consistent with Stage B2. Thoracic radiographs do not show pulmonary edema, and resting respiratory effort is acceptable. The owner focuses on cough relief, but the question asks for most appropriate disease-stage management now. Which option best fits this B2 pattern?",
    "options": {
      "A": "Start hydrocodone only and reassess in 6 months",
      "B": "Start pimobendan for Stage B2 progression delay",
      "C": "Start furosemide immediately for presumed CHF",
      "D": "No cardiac medication because the dog is not dyspneic"
    },
    "correct": "B",
    "explanation": "In DMVD Stage B2 (cardiac enlargement without edema), pimobendan is the tested progression-delay move, even when cough has mixed causes.",
    "decision_framework": "Do not confuse cough symptom management with stage-based cardiac management.",
    "key_triggers": [
      "DMVD confirmed by exam and echo",
      "Cardiomegaly present (B2)",
      "No pulmonary edema, so this is not decompensated CHF"
    ],
    "eliminate_wrong": {
      "A": "Supportive antitussive-only care does not address Stage B2 progression risk.",
      "C": "Diuretic-first therapy is for active congestion/edema, not pre-CHF B2 cases.",
      "D": "No-med logic fits B1, not B2 with documented remodeling."
    },
    "speed_training": "If enlargement is present but edema is absent, think B2 and choose pimobendan.",
    "navle_rule": "Treat DMVD B2; reserve CHF protocol for edema/distress.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_018_acute_cardiogenic_edema_priority",
    "topic": "cardiology",
    "stem": "A known cardiac dog suddenly develops open-mouth breathing, severe tachypnea, and anxiety at rest. Auscultation reveals crackles, and emergency thoracic radiographs demonstrate diffuse pulmonary edema compatible with acute left-sided congestive failure. Several medications are discussed, including chronic remodeling drugs and cough suppressants. In this emergency moment, what is the most appropriate immediate priority?",
    "options": {
      "A": "Wait for complete echo report before treatment",
      "B": "Provide oxygen and loop diuretic stabilization first",
      "C": "Start ACE inhibitor monotherapy and discharge",
      "D": "Treat only with bronchodilator and cough suppressant"
    },
    "correct": "B",
    "explanation": "Acute cardiogenic pulmonary edema is a stabilize-first emergency requiring immediate oxygen and diuresis.",
    "decision_framework": "In respiratory failure from edema, stabilization precedes full chronic-plan optimization.",
    "key_triggers": [
      "Severe dyspnea/tachypnea",
      "Pulmonary edema on thoracic imaging",
      "Immediate oxygenation/perfusion threat"
    ],
    "eliminate_wrong": {
      "A": "Deferring treatment until complete imaging can worsen hypoxemia.",
      "C": "ACE inhibitor-only strategy does not treat urgent pulmonary edema.",
      "D": "Airway symptom drugs do not resolve cardiogenic alveolar fluid burden."
    },
    "speed_training": "Pulmonary edema pattern equals oxygen plus loop diuretic first.",
    "navle_rule": "Acute CHF management is immediate stabilization, then refinement.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_019_heartworm_diagnosis_algorithm",
    "topic": "parasitology",
    "stem": "During annual screening, a clinically stable dog tests antigen-positive for heartworm after imperfect prevention compliance. The patient has no severe respiratory compromise yet, and the team wants to proceed with the safest evidence-based sequence. Before selecting final adulticide timing, you need the algorithmic next step that confirms infection status and helps staging. What should be done next?",
    "options": {
      "A": "Start melarsomine immediately without further confirmation",
      "B": "Perform microfilaria assessment and stage disease before adulticide planning",
      "C": "Ignore result if the dog is asymptomatic",
      "D": "Repeat antigen in 12 months without interim action"
    },
    "correct": "B",
    "explanation": "After antigen positivity, microfilaria evaluation and clinical staging guide safe treatment sequencing.",
    "decision_framework": "Positive screen triggers confirmation/staging workflow, not immediate final-step therapy.",
    "key_triggers": [
      "Antigen test is positive",
      "Need to characterize infection burden and cardiopulmonary impact",
      "Adulticide planning depends on staging data"
    ],
    "eliminate_wrong": {
      "A": "Skipping confirmation/staging can create avoidable treatment risk.",
      "C": "Asymptomatic status does not rule out clinically important disease.",
      "D": "Delaying follow-up ignores an active positive screening result."
    },
    "speed_training": "Antigen-positive means confirm and stage before adulticide sequence.",
    "navle_rule": "Follow algorithm steps in order for heartworm safety.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_020_heartworm_safe_sequence",
    "topic": "parasitology",
    "stem": "A dog with confirmed heartworm infection is being counseled for treatment planning. The owner asks why therapy cannot start with immediate adulticide injection today. You need to choose the protocol sequence that minimizes complications and follows standard risk-reduction workflow, including preparatory treatment and activity restrictions. Which overall sequence is most appropriate?",
    "options": {
      "A": "Melarsomine first-day injection then decide the rest later",
      "B": "Doxycycline and macrocyclic-lactone phase with exercise restriction, then staged 3-dose melarsomine protocol",
      "C": "Only monthly prevention with no other therapy",
      "D": "High-intensity exercise to improve pulmonary flow before treatment"
    },
    "correct": "B",
    "explanation": "Safe sequencing emphasizes preparatory phase and exercise restriction before adulticide protocol execution.",
    "decision_framework": "NAVLE tests treatment order and risk reduction, not just drug name recall.",
    "key_triggers": [
      "Confirmed heartworm infection",
      "Need to lower thromboembolic and inflammatory risk",
      "Adulticide phase should follow preparation"
    ],
    "eliminate_wrong": {
      "A": "Skipping preparatory phase increases complication risk.",
      "C": "Prevention-only approach is not definitive treatment for established disease.",
      "D": "Exercise increases risk during active heartworm disease management."
    },
    "speed_training": "Think prep phase first, then staged adulticide.",
    "navle_rule": "Sequence matters in heartworm treatment safety.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_021_dcm_occult_vs_chf_fork",
    "topic": "cardiology",
    "stem": "A Doberman with known DCM has chamber dilation and ventricular ectopy on monitoring, but current thoracic imaging shows no pulmonary edema and exam does not indicate active congestive failure. The case question focuses on choosing the correct branch between occult disease management and decompensated CHF treatment. What is the most appropriate immediate direction?",
    "options": {
      "A": "Treat as CHF now with high-dose diuretic protocol",
      "B": "Occult DCM pathway: stage-appropriate cardiac therapy plus rhythm follow-up",
      "C": "No treatment until overt collapse occurs",
      "D": "Thoracocentesis as routine first step"
    },
    "correct": "B",
    "explanation": "Occult DCM (no edema) follows a different pathway from congestive DCM and requires proactive management/monitoring.",
    "decision_framework": "Differentiate structural disease with no congestion from true CHF decompensation.",
    "key_triggers": [
      "Chamber dilation present",
      "Arrhythmia risk present",
      "No radiographic/clinical edema signs"
    ],
    "eliminate_wrong": {
      "A": "Diuretic-heavy CHF protocol is for congestion, not occult non-congestive stage.",
      "C": "Delay misses stage-based interventions and rhythm risk control.",
      "D": "Thoracocentesis is for pleural space disease, not this presentation."
    },
    "speed_training": "No edema means occult fork, not CHF fork.",
    "navle_rule": "Apply DCM stage logic before selecting acute therapies.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_022_wide_complex_vt_unstable",
    "topic": "cardiology",
    "stem": "An emergency patient arrives with wide-complex tachyarrhythmia, hypotension, weak pulses, and poor mentation. Team members suggest waiting for extended ECG interpretation before intervention. Because hemodynamic instability is already present, the decision must favor life-saving rhythm logic first. What is the most appropriate immediate approach?",
    "options": {
      "A": "Treat as benign supraventricular rhythm and observe",
      "B": "Assume unstable VT pattern and begin emergency rhythm control",
      "C": "Delay treatment pending outpatient Holter interpretation",
      "D": "Start oral maintenance therapy only and discharge"
    },
    "correct": "B",
    "explanation": "Unstable wide-complex tachycardia in dogs is managed as VT emergency until proven otherwise.",
    "decision_framework": "Hemodynamic stability drives urgency in arrhythmia decisions.",
    "key_triggers": [
      "Wide-complex rapid rhythm",
      "Perfusion compromise/hypotension",
      "Emergency rhythm control needed now"
    ],
    "eliminate_wrong": {
      "A": "Observation-first approach is unsafe in unstable tachyarrhythmia.",
      "C": "Holter is diagnostic follow-up, not immediate stabilization.",
      "D": "Oral outpatient-only strategy is inappropriate in unstable presentation."
    },
    "speed_training": "Wide-complex plus instability equals emergency VT logic.",
    "navle_rule": "Stabilize dangerous rhythm first, refine diagnosis second.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_023_upper_airway_crisis_brachy",
    "topic": "emergency",
    "stem": "A brachycephalic dog presents in hot weather with stridor, cyanosis, severe inspiratory effort, and hyperthermia. The patient is rapidly fatiguing and cannot maintain adequate airflow. The question asks for immediate priority management before any elective or definitive airway surgery planning. Which action is most appropriate right now?",
    "options": {
      "A": "Immediate airway support and active cooling/stabilization",
      "B": "Delay intervention until full laryngeal imaging under sedation",
      "C": "Give cough suppressant and observe response",
      "D": "Focus first on long-term surgical planning only"
    },
    "correct": "A",
    "explanation": "Upper-airway crisis requires rapid airway stabilization and cooling before definitive procedure planning.",
    "decision_framework": "Treat life-threatening airway compromise before elective diagnostics.",
    "key_triggers": [
      "Brachycephalic signalment with inspiratory crisis",
      "Cyanosis and heat-stress physiology",
      "Immediate airway threat"
    ],
    "eliminate_wrong": {
      "B": "Delayed imaging-first strategy is unsafe during active airway failure.",
      "C": "Symptom suppression does not correct critical upper airway obstruction.",
      "D": "Definitive surgery is later; immediate stabilization is first."
    },
    "speed_training": "Airway and cooling first in brachy emergency presentations.",
    "navle_rule": "Stabilization comes before definitive airway correction planning.",
    "source_doc": "main1 for navle.ini"
  },
  {
    "id": "main1_024_ahds_vs_parvo_triage",
    "topic": "infectious-disease",
    "stem": "A 5-month-old puppy is presented with acute bloody diarrhea, vomiting, depression, and leukopenia. A parvo test is pending, but the patient appears clinically high risk and potentially contagious. The team is deciding whether to treat as non-contagious hemorrhagic diarrhea syndrome versus presumptive parvovirus during triage. What is the safest and most appropriate immediate approach?",
    "options": {
      "A": "Treat as non-contagious AHDS and skip isolation",
      "B": "Treat as presumptive parvovirus with isolation and aggressive supportive care",
      "C": "Send home for oral hydration only until test confirmation",
      "D": "Delay treatment until repeat CBC tomorrow"
    },
    "correct": "B",
    "explanation": "In high-risk puppy patterns, biosecurity and parvo-level supportive care should begin immediately while confirmation continues.",
    "decision_framework": "When consequences of missed contagion are high, triage should favor containment and stabilization.",
    "key_triggers": [
      "High-risk age/signalment",
      "Hemorrhagic GI signs with leukopenia",
      "Pending test should not delay critical early care"
    ],
    "eliminate_wrong": {
      "A": "Assuming non-contagious disease early risks outbreaks and delayed critical treatment.",
      "C": "Outpatient-only care is inappropriate for severe high-risk presentation.",
      "D": "Deferring care can worsen shock, sepsis risk, and viral spread."
    },
    "speed_training": "Puppy plus leukopenia plus hemorrhagic diarrhea means isolate and treat as parvo until proven otherwise.",
    "navle_rule": "Use worst-case-safe triage when contagious critical disease is plausible.",
    "source_doc": "main1 for navle.ini"
  }
]
